Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Kos Azmacort HFA Submission In ’07 Could Lead To Removal Of CFC Version

Executive Summary

Kos plans to submit an NDA for Azmacort HFA in the second half of 2007, which would likely lead to the removal of CFC-containing Azmacort

You may also be interested in...



CFC-Only Asthma Drugs Likely To Lose “Essential Use” Designation

FDA is likely to initiate proceedings to revoke the "essential use" designation for remaining chlorofluorocarbon-propelled asthma drug products following a lack of strong support by FDA's Pulmonary-Allergy Drugs Advisory Committee for continued use of any of the products

CFC-Only Asthma Drugs Likely To Lose “Essential Use” Designation

FDA is likely to initiate proceedings to revoke the "essential use" designation for remaining chlorofluorocarbon-propelled asthma drug products following a lack of strong support by FDA's Pulmonary-Allergy Drugs Advisory Committee for continued use of any of the products

CFC Albuterol To Be Pulled In 2008; FDA Says HFA Makers Need Ramp-Up Time

FDA is basing its Dec. 31, 2008 deadline for the withdrawal of CFC-containing albuterol on the concern that manufacturers will need additional time to ramp-up production of hydrofluoroalkane products

Related Content

Topics

UsernamePublicRestriction

Register

PS045673

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel